Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
4.53M
-
Shares change
-
-23.8K
-
Total reported value, excl. options
-
$129M
-
Value change
-
-$3.21M
-
Number of buys
-
36
-
Number of sells
-
-35
-
Price
-
$28.28
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q3 2014
84 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q3 2014.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.53M shares
of 22.3M outstanding shares and own 20.31% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT CO (607K shares), Consonance Capital Management LP (550K shares), Healthcare Value Capital, LLC (350K shares), BlackRock Institutional Trust Company, N.A. (328K shares), WELLS FARGO & COMPANY/MN (242K shares), VANGUARD GROUP INC (224K shares), CASTLEARK MANAGEMENT LLC (179K shares), First Investors Management Co Inc (176K shares), BlackRock Fund Advisors (165K shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (164K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.